Evidence map›Paper›PMID 37501057›Full record

ArticleHarm reduction journal2023

'It's not going to be a one size fits all': a qualitative exploration of the potential utility of three drug checking service models in Scotland.

Hannah Carver, Danilo Falzon, Wendy Masterton, Bruce Wallace, Elizabeth V Aston, Fiona Measham, Carole Hunter, Harry Sumnall, Rosalind Gittins, Fiona Raeburn and 5 more

Open access · goldAbstract read
In one paragraph

Article in Harm reduction journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Interpol review of forensic drug chemistry, 2022-2025.Forensic science international. Synergy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 8 institutions in 2 countries.

Hannah CarverSalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, University of Stirling, Stirling, FK9 4LA, UK. hannah.carver@stir.ac.uk.
Danilo FalzonSalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, University of Stirling, Stirling, FK9 4LA, UK.
Wendy MastertonSalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, University of Stirling, Stirling, FK9 4LA, UK.
Bruce WallaceCanadian Institute for Substance Use Research, University of Victoria, Victoria, BC, V8P 5C2, Canada.
Elizabeth V AstonSchool of Applied Sciences, Edinburgh Napier University, Edinburgh, EH11 4BN, UK.
Fiona MeashamDepartment of Sociology, Social Policy and Criminology, University of Liverpool, Liverpool, L69 7ZR, UK.
Carole HunterAlcohol and Drug Services, NHS Greater Glasgow and Clyde, Glasgow, G51 1DP, UK.
Harry SumnallPublic Health Institute, Liverpool John Moores University, Liverpool, L2 2QP, UK.
Rosalind GittinsVia, London, SW1H 9BL, UK.
Fiona RaeburnNHS Grampian, Royal Cornhill Hospital, Cornhill Road, Aberdeen, AB25 2ZH, UK.
Vicki CraikPublic Health Scotland, Glasgow, G2 6QE, UK.
Saket PriyadarshiAlcohol and Drug Services, NHS Greater Glasgow and Clyde, Glasgow, G51 1DP, UK.
Laura RothneyNHS Grampian, Royal Cornhill Hospital, Cornhill Road, Aberdeen, AB25 2ZH, UK.
Kira WeirCrew2000, Edinburgh, EH1 1PB, UK.
Tessa ParkesSalvation Army Centre for Addiction Services and Research, Faculty of Social Sciences, University of Stirling, Stirling, FK9 4LA, UK.
University of Stirling · GBNHS Grampian · GBNHS Greater Glasgow and Clyde · GBEdinburgh Napier University · GBLiverpool John Moores University · GBPublic Health Scotland · GBUniversity of Manchester · GBUniversity of Victoria · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundScotland currently has the highest rates of drug-related deaths in Europe, so drug checking services are being explored due to their potential role in reducing these deaths and related harms. Drug checking services allow individuals to submit presumed psychoactive drug samples for analysis, and then receive individualised feedback and counselling. This paper explores participants' views on the advantages and challenges of three hypothetical service models, to inform future service delivery in Scotland.

methodsSemi-structured interviews were conducted with 43 people: 27 professional stakeholders, 11 people with experience of drug use, and five family members across three cities. Vignettes were used to provide short descriptions of three hypothetical service models during the interviews. Interviews were audio-recorded, transcribed and analysed using thematic analysis.

resultsParticipants identified advantages and challenges for each of the three potential service models. The third sector (not-for-profit) model was favoured overall by participants, and the NHS substance use treatment service was the least popular. Participants also noted that multiple drug checking sites within one city, along with outreach models would be advantageous, to meet the diverse needs of different groups of people who use drugs.

conclusionsDrug checking services need to be tailored to local context and needs, with a range of service models being possible, in order to meet the needs of a heterogeneous group of people who use drugs. Addressing issues around stigma, accessibility, and concerns about the potential impact of accessing drug checking on access to and outcomes of drug treatment, are essential for successful service delivery.

Indexed as

Pharmaceutical ServicesSubstance-Related DisordersCounselingEuropeHumansScotlandDrug checking servicesDrug related deathsDrug use interventionHarm reductionPublic healthQualitative researchScotlandService deliverySubstance use

Identifiers

PMID37501057
PMCPMC10373262
OpenAlexW4385330385

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.